Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.

about

Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.

P2860

Q45871879-49B96A17-3E6D-4693-81AC-7E78FD6B7AA6

P2860

Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.

Item

http://www.wikidata.org/entity/Q38823260

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Planes, Trains, and Automobile ...... for Hematologic Malignancies.

@en

type

Item

label

Planes, Trains, and Automobile ...... for Hematologic Malignancies.

@en

prefLabel

Planes, Trains, and Automobile ...... for Hematologic Malignancies.

@en

P1476

Planes, Trains, and Automobile ...... for Hematologic Malignancies.

@en

P2093

Saar Gill

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy

Application of IL-2 therapy to target T regulatory cell function

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

Nivolumab plus ipilimumab in advanced melanoma.

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

P2888

s11899-016-0330-5

P304

318-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S11899-016-0330-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033152786

http://www.w3.org/2001/XMLSchema#string

P698

27136938

http://www.w3.org/2001/XMLSchema#string

P932

5018307

http://www.w3.org/2001/XMLSchema#string

Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.

about

P2860

P2860

Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932